Ajinomoto Co., Ltd.

Azbil Corporation

Takashi Komiyama

Ryota Yoshimoto

Hideaki Kihara

Yoshinori Monaka

Hiroshi Sigematsu

Kentaro Kitahori

Ken Hirose

Channels, which are assigned to each individual lower-level device that are the input/output destinations for HART communications signals that are produced through superimposing, onto a 4 to 20 mA DC signal, digital signals that have been converted into 1200 Hz and 2200 Hz frequency signals; a first controlling portion for controlling communications with a higher-level device; and HART communications portions, provided for each individual channel, for extracting frequency signals from the HART communications signals received through the channels, and for sending to the controlling portion digital signals corresponding to the frequency signals, are provided; where the first controlling portion sends, to the higher-level device, the digital signals received from the individual HART communications portions.

Input/output device having hart communications functions

A compound 1-formyl-N-(2-(4-(5H-dibenzo&lsqb;a,d&rsqb;cyclohepten-5-ylidene)-1-piperidinyl)) ethyl isonipecotic acid amide or an analog thereof or a pharmaceutically acceptable salt thereof provides a therapeutic agent for treating a patient suffering from intermittent claudication.

Therapeutic agent for intermittent claudication

Growing community of inventors

Tokyo, Japan

Takashi Komiyama